The Government of India has come out with guidelines for funding of testing facilities, infrastructure, and institutional support for development of standards and regulatory framework under the National Green Hydrogen Mission. The Scheme Guidelines have been issued by the Ministry of New & Renewable Energy (MNRE) on July 4, 2024.
The scheme will support identification of the gaps in the existing testing facilities for components, technologies, and processes in the value chain of green hydrogen & its derivatives. The scheme will support creation of new testing facilities and upgradation of existing testing facilities to ensure safe and secure operations.
The scheme will be implemented with a total budgetary outlay of Rs.200 crore till FY26. The National Institute of Solar Energy (NISE) will be the Scheme Implementation agency (SIA).
The scheme encompasses the development of robust quality and performance testing facilities to ensure quality, sustainability, and safety in GH2 production and trade.
The scheme guidelines may be accessed here. (External link)
Rationale
Discussing the rationale of the new scheme, the detailed guideline note states that testing centres developed and upgraded under the scheme will bridge the gap in existing testing infrastructure for various components of the green hydrogen value chain in the country. The scheme is also expected to lead to establishment of new testing facilities and upgrade of existing ones so as to achieve self-sufficiency in areas of testing and certification for the green hydrogen value chain.
National GH2 Mission
The National Green Hydrogen Mission was launched on 4th January 2023, with an outlay of Rs.19,744 crore up to FY30. It will contribute to India’s goal to become Aatma Nirbhar (self-reliant) through clean energy and serve as an inspiration for the global Clean Energy Transition. The Mission will lead to significant decarbonization of the economy, reduced dependence on fossil fuel imports, and enable India to assume technology and market leadership in Green Hydrogen.
Featured photograph is for representation only.
